Finley John David bought PALI
October 6, 2026 · Form 4 insider transaction
Finley John David bought 3,227,384 shares of Palisade Bio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,227,384
Price
N/A
Total value
N/A
InsiderFinley John David
Role—
CompanyPalisade Bio, Inc. (PALI)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 6, 2026
Filing dateOctober 7, 2026
Shares owned after3,356,672
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").